Here are Pauli’s preliminary comments as Raisio reports its Q3 results next week on Tuesday. 
We estimate that the company’s positive earnings development continued in Q3, supported by, among other things, the divestment of plant proteins, positive volume development especially in Elovena products, and a stable cost environment. The company continues its systematic work to grow its consumer business, but grain price developments may have a small negative impact on revenue, mainly through B2B sales. In our view, the company could specify its earnings growth in the Q3 report.